Recombinant PCSK9 (Frovocimab Biosimilar) antibody
The Human Monoclonal anti-PCSK9 (Frovocimab Biosimilar) antibody has been validated for ELISA, BLI, FACS, Func and SPR. It is suitable to detect PCSK9 (Frovocimab Biosimilar) in samples from Human.
Catalog No. ABIN7675967
-15% Promotion 2026
$294.23
save $51.92 (-15 %)
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 11 Business Days
Quick Overview for Recombinant PCSK9 (Frovocimab Biosimilar) antibody (ABIN7675967)
Target
PCSK9 (Frovocimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This PCSK9 (Frovocimab Biosimilar) antibody is un-conjugated
Application
ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-PCSK9 Reference Antibody (frovocimab)
-
Characteristics
- Anti-PCSK9 Reference Antibody (frovocimab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG4 S228P
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- PCSK9 (Frovocimab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- Q8NBP7
Target
-
You are here:
